Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • christinawu2008
    Member
    • Feb 2011
    • 13

    questions about choosing read coverage

    Hi everyone,

    It sounds stupid question... but I really want to know how you guys choose the read coverage before sequencing. I know it is related to the cost. But What is the minimum size and what is the best choice? and why? any rules here? (illumina)

    Some useful link will be great..

    Thank you!
    Last edited by christinawu2008; 04-28-2011, 05:08 PM.
  • suludana
    Member
    • May 2008
    • 61

    #2
    Hi,

    the necesary coverage depends on the proyect you are performing. For instance, if you are doing de novo sequencing probably you will need at least 30-50x, but if you are doing resequencing a 10-20x can be enough.

    The way to calculate these values is:

    The number of clusters you have per sample (read1 + read2 if it is a PE run) x read lenght / aproximate size of the sequence you are studing.

    I hope this explanation will help you.

    Comment

    • Heisman
      Senior Member
      • Dec 2010
      • 534

      #3
      On top of what suludana said, generally when aligning it isn't possible to align 100% of the reads. Maybe only 50-90% depending on the type of data that is being generated, so that should be factored in as well. If you want to remove low quality bases for whatever reason (for example, trim the last 30 bases of a 101 paired end read), then that needs to also be factored in.

      Comment

      • christinawu2008
        Member
        • Feb 2011
        • 13

        #4
        Originally posted by suludana View Post
        Hi,

        the necesary coverage depends on the proyect you are performing. For instance, if you are doing de novo sequencing probably you will need at least 30-50x, but if you are doing resequencing a 10-20x can be enough.

        The way to calculate these values is:

        The number of clusters you have per sample (read1 + read2 if it is a PE run) x read lenght / aproximate size of the sequence you are studing.

        I hope this explanation will help you.
        Hi suludana,

        Thank you!

        Are there any literatures described how large is the expected read output (Gbases) for each sample in illumina RNA-Seq? (mammalian) if the genome is 3Gbases.

        Comment

        • trickytank
          Member
          • Dec 2010
          • 19

          #5
          We find that detecting heterozygous variates reliably is more difficult than detecting homozygous variants. If your samples are not from a consangous pedigree than I'd be aiming for 20x plus to avoid the false positives.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          30 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          41 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Working...